The Dangerous Fat You Can’t See (Even Slim People Have It!)
Vorschaubild von YouTube. Abspielen lädt den YouTube-Player.
Verlauf & EmpfehlungenAus
Zuletzt angesehene Inhalte in diesem Browser behalten. Dein Verlauf bleibt auf diesem Gerät und wird nicht an Harbor gesendet. Abgespielte Videos können auch passende Videoempfehlungen sortieren.
Merkliste & Verlauf öffnen →Über dieses Video
Creator-Beschreibung · OriginaltextTextsprache: Englisch (Vereinigtes Königreich)
https://www.dralexnewsletter.com Join the community by signing up to my daily newsletter! Practical health advice, straight to your inbox, every morning.
There is a type of fat that you cannot see, cannot pinch, and cannot measure properly on a bathroom scale.... and it may be one of the biggest hidden drivers of heart disease, type 2 diabetes, fatty liver disease and even dementia.
It is called VISCERAL FAT.
Unlike the fat under your skin, visceral fat is stored deep inside the abdomen, wrapped around the liver, intestines and other organs. And biologically, it behaves completely differently. It acts less like passive energy storage and more like an inflammatory organ, continuously releasing fatty acids, hormones and inflammatory signals directly into the liver through the portal vein.
In this video, I break down:
-What visceral fat actually is
-Why BMI can completely miss it
-Why slim people can still carry dangerous levels of it
-The link between visceral fat and insulin resistance
-How it drives heart disease, fatty liver and dementia
-Why poor sleep and chronic stress specifically increase abdominal fat
-The role of cortisol, inflammation and the liver
-Why muscle mass protects against metabolic disease
-What waist-to-height ratio tells you about your health
-The evidence behind exercise, diet and fasting for reducing visceral fat
One of the most important things to understand is that visceral fat is highly responsive to change. The same metabolic activity that makes it dangerous also makes it one of the first fat stores the body draws on when sleep improves, movement increases, insulin levels fall, and the metabolic environment changes. So please feel encouraged by this video!!
TIMESTAMPS
00:00 Introduction
02:52 What is visceral fat — and why is it so different?
07:11 What visceral fat actually looks like inside the body
10:58 High versus low visceral fat in real people
14:41 Why visceral fat goes straight to the liver
21:17 The chain to heart disease, diabetes and dementia
27:33 What causes visceral fat accumulation
33:43 What actually reduces visceral fat
43:19 Closing thoughts
REFERENCES
Body fat distribution, incident cardiovascular disease, cancer, and all-cause mortality (Framingham Heart Study)
https://pubmed.ncbi.nlm.nih.gov/23850922/
Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement
https://pubmed.ncbi.nlm.nih.gov/31301983/
Pathophysiology of human visceral obesity: an update
https://pubmed.ncbi.nlm.nih.gov/23303913/
A dose-response relation between aerobic exercise and visceral fat reduction: systematic review of clinical trials
https://pubmed.ncbi.nlm.nih.gov/17637702/
Impact of sleep debt on metabolic and endocrine function
https://pubmed.ncbi.nlm.nih.gov/10543671/
Central obesity and increased risk of dementia more than three decades later
https://pubmed.ncbi.nlm.nih.gov/18367704/
Type 2 diabetes mellitus and psychological stress — a modifiable risk factor
https://pubmed.ncbi.nlm.nih.gov/28664919/
Understanding weight gain at menopause
https://pubmed.ncbi.nlm.nih.gov/22978257/
Evidence for resistance training as a treatment therapy in obesity
https://pubmed.ncbi.nlm.nih.gov/20847892/
A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0.5 could be a suitable global boundary value
https://pubmed.ncbi.nlm.nih.gov/20819243/
Association of alcohol consumption with fat deposition: the Shiga Epidemiological Study of Subclinical Atherosclerosis (SESSA)
https://pubmed.ncbi.nlm.nih.gov/29848904/
Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: the INTERHEART case-control study
https://pubmed.ncbi.nlm.nih.gov/16271645/
Disclaimer: This video is for educational purposes only and should not replace personalised medical advice from your own doctor or healthcare professional.
#visceralfat #insulinresistance #heartdisease #fattyliver #metabolichealth #longevity #type2diabetes #dementia #preventativemedicine #dralex #doctoralex
Doctor Alex · 47 min · Quelle veröffentlicht: 2026-05-15
Zu Harbor hinzugefügt: 23.10.2026
Original auf YouTube ↗Automatisch eingeordnete Quelle. Creator-Aussagen sind keine unabhängige Evidenzprüfung und keine persönliche medizinische Beratung.